论文部分内容阅读
为进一步研究抗-HBc阳性者的免疫状态,我们于1985年9月对江苏某校部分抗-HBc阳性者接种了乙肝疫苗(美国Merck疫苗)。材料和方法一、对象:某校111例学生,男63例,女48例。年龄15～22岁,平均18岁。既往均无肝炎史,HBsAg、抗-HBs均阴性,肝功能(SGPT、ZnTT)、均正常,肝脾不肿大。二、分组及免疫程序;根据抗-HBcIgG检测结果分成二组:抗-HBcIgG阳性60例为观察组,男34例,女26例;抗-HBcIgG阴性51例为对照组,男29例,女22例。又根据疫苗含量多少,注射部位不同分为三组:一组上臂三角肌
To further investigate the immune status of anti-HBc positive individuals, we vaccinated a portion of anti-HBc positive individuals in a school in Jiangsu in September 1985 for hepatitis B vaccine (Merck vaccine, U.S.A.). Materials and methods First, the object: a school of 111 students, 63 males and 48 females. Aged 15 to 22 years old, average 18 years old. None of the past history of hepatitis, HBsAg, anti-HBs were negative, liver function (SGPT, ZnTT), were normal, hepatosplenomellia did not enlarge. According to the results of anti-HBcGG test, the patients were divided into two groups: anti-HBcIgG positive 60 cases as observation group, 34 males and 26 females; anti-HBcIgG negative 51 cases as control group, 29 males and females 22 cases. And according to the vaccine content, the injection site is divided into three different groups: a group of upper arm deltoid